Maito, Alfhaiser M.
HRN: 16-23-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
METRONIDAZOLE 500MG (TAB)
05/28/2023
06/05/2023
ORAL
500mg
Tid
Thickly MSAF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes